Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SagaPro for nocturia in men
2010-019668-35Phase 2Completed
- Sponsor
- SagaMedica
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nocturia and benign prostatic hyperplasia (BPH) comparing SagaPro arm with Placebo arm (2 arms). Primary endpoint: Change in number of nocturnal voids. Started Mar 2010; status: completed.
02
Drugs
angelica archangelica leaf extract
03
Conditions
nocturiabenign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2010-019668-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019668-35.